Pharma News, Research & Solutions CSR News

An Open Letter from our Chairman and CEO

Blog

Daniel O'Day
 

When the news of the coronavirus first emerged, Gilead immediately began to investigate the potential of remdesivir, a medicine we had been studying for many years as part of our extensive research in antivirals. Remdesivir had never been approved for use but based on what we had learned to date, we knew it might have potential with the novel coronavirus. Since then, we have been working with the greatest sense of urgency and responsibility to determine whether remdesivir does indeed work against COVID-19.

COVID-19 Therapeutics Accelerator Awards $20 Million in Initial Grants to Fund Clinical Trials

Researchers at three institutions in the U.S. and U.K. receive grants to advance studies of repurposed drugs and novel antibodies in preventing COVID-19
Press Release

PURCHASE, NY – March 31, 2020 /3BL Media/ – The partners in the COVID-19 Therapeutics Accelerator have announced grants of $20 million to three institutions—the University of Washington, University of Oxford, and La Jolla Institute for Immunology—to fund clinical trials in order to identify highly potent immunotherapies for the COVID-19 pandemic.

What You Need to Know About How Johnson & Johnson's Supply Chain Is Responding to the Covid-19 Pandemic

The company's Chief Global Supply Chain Officer shares the measures the company has taken to maintain its supply chain operations during the current novel coronavirus outbreak.
Article

The effects of the global Covid-19 pandemic are undeniable.

As the world rapidly learns to adapt to an ever-changing landscape, Johnson & Johnson's supply chain, which produces everything from contact lenses to prescription medications to fever reducers, is currently holding steady and meeting patient needs.

Medtronic Perspective: Collaborating to Improve Global Health Access

Article

Despite the unprecedented advances in healthcare, the benefits of progress are not being shared equally among all populations. Many treatments and services that have become the standard of care in some areas remain inaccessible to others. The result is inequality in diagnosis and treatment — and most importantly, in health outcomes — for the most prevalent diseases.

Read more.

The Drug Enforcement Administration and Discovery Education Introduce Digital Workplace Training to Combat Opioid Epidemic

Employees and Employers Empowered with No-Cost Educational Resources Addressing Opioid Misuse Prevention
Press Release

SILVER SPRING, Md., March 5, 2020 /3BL Media/ – The Operation Prevention program, created in partnership with the Drug Enforcement Administration (DEA) and Discovery Education, today announced a four-part digital module series to educate workplace professionals about the opioid epidemic and provide resources for prevention.

Cracking the Genetic Code: Why Gene Sequencing May Hold the Key to Intercepting Diseases Before They Start

By Hallie Levine
Summary: 

Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.

Article

Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.

From Doctor to Researcher: Meet a Woman Who's Spent Much of Her Career Fighting Prostate Cancer

For Prostate Cancer Awareness Month, we sat down with Margaret Yu, M.D., Vice President, Disease Area Leader, Prostate Cancer, Janssen Research & Development, to learn more about the latest scientific strides being made in the battle against one of the mo
Article

By Darren Frei

There’s promising news in the fight against prostate cancer: According to a recent study conducted by the American Cancer Society, incidence of the disease—as well as deaths from prostate cancer—have been decreasing or stabilizing in most countries around the world.

HP’s Christoph Schell Dreams in 3D

The president of 3D Printing and Digital Manufacturing anticipates a sustainable future and how consumers — and the planet — will benefit from the fourth industrial revolution.
Blog

By Roland Jones

Any parent whose child needs orthodontia knows that there are two kinds of pain that come with the traditional teeth straightening process. There’s the unavoidable pain of moving canines and cuspids, and then there’s the financial pain of paying for it.

P&O Cruises Guests Help Save Lives of Newborn Babies in PNG With Their Contributions to P&O Pacific Partnership

Press Release

July 16, 2019 /3BL Media/ A tiny bracelet is helping to save the lives of thousands of newborn babies in PNG and P&O Cruises’ guests are playing a part through the power of their one dollar contributions to the P&O Pacific Partnership.

PNG has one of the world’s highest infant mortality rates with 6,000 babies dying each year before the age of four weeks, in many cases due to hypothermia caused by a sudden fall in body temperature.

Can You Imagine Overseeing the Safety of Thousands of Product Ingredients? This Johnson & Johnson Scientist Can

By Kurt Reynertson, as told to Nicole Frehsee Mazur
Summary: 

Ever wonder what's in the mouthwash, lotion or shampoo you use? Kurt Reynertson knows everything there is to know about the ingredients in the company's consumer products—and the measures Johnson & Johnson takes to keep you safe.

Blog

Ever wonder what's in the mouthwash, lotion or shampoo you use? Kurt Reynertson knows everything there is to know about the ingredients in the company's consumer products—and the measures Johnson & Johnson takes to keep you safe.

Pages

Subscribe to Pharma News, Research & Solutions